Best Researcher Award
Mohammad Hossein Pourhanifeh
Kashan University of Medical Sciences, Iran
Mohammad Hossein Pourhanifeh is a researcher affiliated with Kashan University of Medical Sciences whose scholarly record is associated with biochemistry and biomedical research. His documented publication portfolio includes research and review articles addressing melatonin, cancer biology, oxidative stress, inflammation, apoptosis, autophagy, non-coding RNAs, angiogenesis, and therapeutic approaches to disease. His reported Scopus record comprises 63 documents, 3,730 citations, and an h-index of 34, providing a bibliometric basis for consideration within the Best Researcher Award category.[1] [2] [3]
Abstract
The Best Researcher Award profile for Mohammad Hossein Pourhanifeh summarizes a scholarly record centered on biomedical and biochemical research. His documented work encompasses mechanistic reviews and therapeutic investigations involving melatonin, cancer-associated signaling, oxidative stress, inflammation, apoptosis, autophagy, angiogenesis, and disease progression. His publications include studies addressing lymphoma, melanoma, neuroblastoma, glioblastoma, multiple myeloma, intervertebral disc degeneration, COVID-19 therapeutics, and diabetes-related research. [1] [4] The supplied bibliometric profile reports 63 indexed documents, 3,730 citations, and an h-index of 34.
Keywords
Mohammad Hossein Pourhanifeh; Best Researcher Award; Kashan University of Medical Sciences; Biochemistry; biomedical research; melatonin; cancer biology; oxidative stress; apoptosis; autophagy; angiogenesis; therapeutic research; molecular biology; pharmacology.
Introduction
Biomedical research frequently integrates biochemical mechanisms with clinical and translational questions. Within this context, research on melatonin has attracted attention because of its reported relationships with oxidative stress, inflammatory signaling, programmed cell death, autophagy, angiogenesis, and cellular responses associated with cancer and tissue injury. Pourhanifeh’s publication record includes multiple reviews examining these mechanisms across different disease models and therapeutic contexts. [2]
Research Profile
Mohammad Hossein Pourhanifeh is identified in the supplied academic information as being affiliated with Kashan University of Medical Sciences in Iran and working within the subject area of biochemistry. The profile is associated with Scopus Author ID 57205343272 and ORCID 0000-0002-6752-2765. The reported bibliometric indicators are 63 documents, 3,730 citations, and an h-index of 34. These figures are presented as the supplied profile data and may change as bibliographic databases are updated.
Research Contributions
A prominent component of the supplied research record is the investigation of melatonin as a potential therapeutic or mechanistic agent. The 2022 review on lymphoma examines current evidence concerning melatonin in the context of lymphoma treatment, while related publications consider melanoma, neuroblastoma, and degenerative intervertebral disc disease. [1] [2]
Publications
The following selected publications are drawn from the supplied bibliographic record. DOI links are provided for direct identification of the corresponding articles.
- Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence. Fundamental & Clinical Pharmacology (2022).
- Anti-degenerative effect of melatonin on intervertebral disc: protective contribution against inflammation, oxidative stress, apoptosis, and autophagy. Current Drug Targets (2022).
- RdRp inhibitors and COVID-19: Is molnupiravir a good option? Biomedicine & Pharmacotherapy (2021).
- Therapeutic Application of Melatonin in the Treatment of Melanoma: A Review. Current Cancer Therapy Reviews (2021).
- Roles of Non-coding RNAs and Angiogenesis in Glioblastoma. Frontiers in Cell and Developmental Biology (2021).
Research Impact
The supplied bibliometric profile reports 3,730 citations and an h-index of 34 across 63 documents. These indicators provide quantitative measures of the visibility and citation activity associated with the researcher’s indexed publication record. Bibliometric measures should be interpreted in relation to field, publication age, database coverage, collaboration patterns, and citation practices rather than as standalone measures of research quality.
Award Suitability
The Best Researcher Award recognizes scholarly activity that can be evaluated through research output, subject-matter contribution, publication record, citation indicators, and relevance to an academic field. Based on the supplied information, Pourhanifeh’s profile presents several characteristics that are pertinent to such an assessment, including a substantial indexed publication record, a reported h-index of 34, and 3,730 citations.
Conclusion
Mohammad Hossein Pourhanifeh’s supplied academic profile reflects a research program focused on biochemistry and biomedical questions, with particular emphasis on melatonin, cancer biology, cellular stress mechanisms, inflammation, apoptosis, autophagy, angiogenesis, and therapeutic development. His publication record includes reviews and research contributions addressing a range of diseases and therapeutic candidates. [1]
External Links
References
- Moradian, F.; Pourhanifeh, M. H.; Mehrzadi, S.; Karimi-Behnagh, A.; Hosseinzadeh, A. (2022). Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence. Fundamental & Clinical Pharmacology.
DOI: https://doi.org/10.1111/fcp.12780
- Pourhanifeh, M. H. (2022). Anti-degenerative effect of melatonin on intervertebral disc: protective contribution against inflammation, oxidative stress, apoptosis, and autophagy. Current Drug Targets.
DOI: https://doi.org/10.2174/1389450123666220114151654
- Pourhanifeh, M. H. (2021). RdRp inhibitors and COVID-19: Is molnupiravir a good option? Biomedicine & Pharmacotherapy.
DOI: https://doi.org/10.1016/j.biopha.2021.112517
- Pourhanifeh, M. H. (2021). Therapeutic Application of Melatonin in the Treatment of Melanoma: A Review. Current Cancer Therapy Reviews.
DOI: https://doi.org/10.2174/1573394717666210526140950
- Pourhanifeh, M. H. (2021). Roles of Non-coding RNAs and Angiogenesis in Glioblastoma. Frontiers in Cell and Developmental Biology.
DOI: https://doi.org/10.3389/fcell.2021.716462